Journals / Nöropsikiyatri Arşivi / 2012 / Cilt: 49 - Sayı: 1

Isaacs sendromu - botulinum toksini tip a’ya klinik ve elektrofizyolojik yanıt

Isaacs’ syndrome - clinical and electrophysiological response to botulinum toxin type a

Pages
77–79
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In our opinion, clinicians may consider botulinum toxin type A in either the diagnosis or the treatment of IS.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Isaacs’ syndrome (IS) is characterized by generalized muscle twitching, stiffness, cramps and continuous muscle-fiber activity.
📊
Key Findings & Data:Here we report a case of 21-year- old male with IS whose continuous muscle-fiber activity diminished clinically and was documented on electromyography by Botulinum type A toxin injection.
💡
Conclusion & Impact:In our opinion, clinicians may consider botulinum toxin type A in either the diagnosis or the treatment of IS.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Isaacs’ syndrome (IS) is characterized by generalized muscle twitching, stiffness, cramps and continuous muscle-fiber activity. Therapy is based on antiepileptic drugs such as phenytoin and carbamazepine. Here we report a case of 21-year- old male with IS whose continuous muscle-fiber activity diminished clinically and was documented on electromyography by Botulinum type A toxin injection. In our opinion, clinicians may consider botulinum toxin type A in either the diagnosis or the treatment of IS.

Özet

Isaacs sendromu (IS), yaygın kas seğirmesi, sertlik, kramp ve sürekli kas lifi aktivitesi ile karakterizedir. Tedavinin temelinde fenitoin ve karbamazepin gibi antiepileptik ilaçlar vardır. Biz burada, Botulinum tip A toksini enjeksiyonu sonrasında devamlı kas lifi etkinliği klinik olarak azalan ve elektromiyografi ile de elektrofizyolojik olarak azaldığı gösterilen 21 yaşında bir erkek IS olgusu sunuyoruz. Bize göre klinisyenler IS tanı veya tedavisinde botulinum toksini tip A’yı düşünebilirler.

🔖

Cite This Article

ÖZ, O., YÜCEL, M., AKGÜN, H., ULAŞ, Ü. H., DEMİRKAYA, Ş., GÖKÇİL, Z., ODABAŞI, Z. (2012). Isaacs sendromu - botulinum toksini tip a’ya klinik ve elektrofizyolojik yanıt. Nöropsikiyatri Arşivi, Cilt: 49 - Sayı: 1, 77–79. https://ajindex.com/articles/292673

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (19)

  1. Isaacs H. A syndrome of continuous muscle fiber activity. J Neurol Neurosurg Psychiatry 1961; 24:319-25
  2. Maddison P. Neuromyotonia. Clin Neurophysiol 2006; 117:2118-27
  3. Auger RG. AAEM minimonograph #44: diseases associated with excess motor unit activity. Muscle Nerve 1994; 17:1250-63
  4. Newsom-Davis J, Mills KR. Immunological associations of acquired neuromyotonia (Isaacs’ syndrome): report of five cases and literature review. Brain 1993; 116:453-69
  5. Lee EK, Maselli RA, Ellis WG, et al. Morvan’s fibrillary chorea: a paraneoplastic manifestation of thymoma. J Neurol Neurosurg Psychiatry 1998; 65:857-62
  6. Odabasi Z, Joy JL, Claussen GC, et al. Isaacs’ syndrome associated with chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 1996; 19:210-5
  7. Jamieson PW, Katirji MB. Idiopathic generalized myokymia. Muscle Nerve 1994; 17:42-51
  8. Dhand UK. Isaacs’ Syndrome: Clinical and electrophysiological response to gabapentin. Muscle Nerve 2006; 34:646-50
  9. Maddison P, Mills KR, Newsom-Davis J. Clinical electrophysiological characterization of the acquired neuromyotonia phenotype of autoimmune peripheral nerve hyperexcitability. Muscle Nerve 2006; 33:801-8
  10. Tanosaki M, Baba M, Miura H, et al. Reversible F-wave hyperexcitability associated with antibodies to potassium channels in Isaacs’ syndrome. Eur J Neurol 1999; 6:95-8
  11. Alessi G, De Reuck J, De Bleecker J, et al. Successful immunoglobulin treatment in a patient with neuromyotonia. Clin Neurol Neurosurg 2000; 102:173-5
  12. Çakmur R. Botulinum Toxin Treatment of Blepharospasm and Hemifacial Spasm. Archives of Neuropsychiatry 2010; 47(Supll 1): 6-10
  13. Kütükçü Y. Treatment of Cervical Dystonia with Botulinum Toxin. Archives of Neuropsychiatry 2010; 47(Supll 1):11-4
  14. Uzun Adatepe N. Extremity and Truncal Dystonias: Botulinum Toxin Applications. Archives of Neuropsychiatry 2010; 47(Supll 1):19-26
  15. Matur Z, Gülşen Parman Y. Treatment of Writer’s Cramp with Botulinum Toxin Type A. Archives of Neuropsychiatry 2010; 47(Supll 1):27-9
  16. Matur Z, Gülşen Parman Y. Use of Botulinum Toxin Type a in the Treatment of Spasticity. Archives of Neuropsychiatry 2010; 47 (Supll 1):40-43
  17. Bora Tokçaer A. Treatment of Tremor with Botulinum Toxin. Archives of Neuropsychiatry 2010; 47(Supll 1):35-9
  18. Hanagasi HA. Hypersecretory Disorders and Botulinum Toxin. Archives of Neuropsychiatry 2010; 47(Supll 1):48-51
  19. Ertaş M. Botulinumtoxin in Pain Treatment. Archives of Neuropsychia